Lawmakers, advocates press for diversity in clinical trials
Despite some steps Congress took last year to improve diversity among trial subjects, lawmakers and advocates are pushing for more, including at NIH.
A clinical-research coordinator at Oregon Health and Science University's Knight Cancer Institute in Portland, Ore., draws blood from a clinical-study participant in March 2022. (AP Photo/Gillian Flaccus)
You are currently accessing National Journal from IP access. Please login to access this feature. If you have any questions, please contact your Dedicated Advisor.
